Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1Breast 1

Conditions

Pancreatic Neoplasms 2Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 135Fluorouracil 129Gemcitabine 114Bevacizumab 111Specimen Handling 101Leucovorin 101Capecitabine 87Magnetic Resonance Spectroscopy 81pembrolizumab 78Cisplatin 74Nivolumab 70Irinotecan 68Cetuximab 58130-nm albumin-bound paclitaxel 58durvalumab 57Paclitaxel 57Biopsy 55atezolizumab 42Radiotherapy 40Albumin-Bound Paclitaxel 36Taxes 35Folfox protocol 34Carboplatin 34Drug Therapy 28lenvatinib 27sintilimab 26dehydroftorafur 26Radiation 26Cyclophosphamide 26tislelizumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breath Tests × Gastrointestinal × 90 days × Clear all
NCT07243262 2026-05-19

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Imperial College London

Recruiting
6,079 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05727020 2026-05-18

VAPOR

Imperial College London

Recruiting
1,005 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04620538 2026-03-30

VOCAL

Imperial College London

Completed
56 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡